The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
Abstract Chemotherapy-induced peripheral neuropathic pain (CIPN) is a common and severe debilitating side effect of many widely used cytostatics. However, there is no approved pharmacological treatment for CIPN available. Among other substances, oxaliplatin causes CIPN in up to 80% of treated patien...
Guardado en:
Autores principales: | Stephan W. Hohmann, Carlo Angioni, Sorin Tunaru, Seungkyu Lee, Clifford J. Woolf, Stefan Offermanns, Gerd Geisslinger, Klaus Scholich, Marco Sisignano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e74672e0a2c4692add969dc360ea3e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1
por: Sorin Tunaru, et al.
Publicado: (2018) -
Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity
por: Kazuaki Nagasaka, et al.
Publicado: (2017) -
Acta No. 132
por: Banco Central de Chile
Publicado: (2019) -
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice
por: Lawrence M. Carey, et al.
Publicado: (2017) -
Resolución 132(VII): Sustitución de importaciones = Resolution 132(VII): Import substitution = Résolution 132(VII): Substitution des importations
Publicado: (2014)